Bloomberg with the report on Brazil's testing of Sinovac Biotech vaccine contender, Coronavac
- final-stage trial of a Chinese frontrunner vaccine candidate has been halted
- due to a serious adverse event
- event that occurred on Oct. 29
- no further detail was provided
